Last reviewed · How we verify

Ritalin (methylphenidate)

Alza Corporation, DE, USA · Phase 3 active Small molecule

Ritalin (methylphenidate) works by increasing the levels of dopamine and norepinephrine in the brain, which helps to improve attention and reduce impulsivity.

Ritalin (methylphenidate) works by increasing the levels of dopamine and norepinephrine in the brain, which helps to improve attention and reduce impulsivity. Used for Attention deficit hyperactivity disorder (ADHD).

At a glance

Generic nameRitalin (methylphenidate)
SponsorAlza Corporation, DE, USA
Drug classCentral nervous system stimulant
ModalitySmall molecule
Therapeutic areaAttention deficit hyperactivity disorder (ADHD)
PhasePhase 3

Mechanism of action

Methylphenidate is a central nervous system stimulant that blocks the reuptake of dopamine and norepinephrine, allowing these neurotransmitters to remain in the synaptic cleft for a longer period. This leads to increased activity in the brain's reward and attention systems, resulting in improved focus and reduced impulsivity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results